Celltrion Healthcare Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
4 result(s) found, displaying 1 to 4
-
Australian Public Assessment Report (AusPAR)Vegzelma (bevacizumab), in combination with fluoropyrimidine-based chemotherapy, has been approved for the treatment of metastatic colorectal cancer.
-
Australian Public Assessment Report (AusPAR)AusPAR for Yuflyma (adalimumab) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis etc.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Regdanvimab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment for Rituximab